Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cardinal Health (CAH) is a stock that can certainly grab the ...

Indiana University said it found plagiarism allegations against Pamela Whitten to be without merit. Experts and scholars ...

Pharmaceuticals, medical and laboratory products distributor Cardinal Health will open a new distribution center in Fort Worth, TX. The 340,000-square-foot facility will support the company’s at-Home ...

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

Proper storage of medical products is critical due to their potential sensitivity to environmental conditions, such as ...

Ontario Health atHome CEO Cynthia Martineau was terminated Tuesday, following reports that home care doctors and patients could not access basic medical supplies.

A University of Minnesota Medical School research team has examined the financial burden of different medical ...

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...